SAIED SHEMIRANEI: Open Payments
NPI 1871951970 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 15 payments from 7 companies in 2025. Trend: 2023 $552 · 2024 $473 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $348 |
| Verity Pharmaceuticals Inc. | 2 | $176 |
| ABBVIE INC. | 4 | $173 |
| Eisai Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
Products named: BREZTRI, Tlando, VRAYLAR, Leqembi, ZEPBOUND, Wegovy, VIVITROL.
Industry payments across FL — which companies pay providers there.
